Healthtech Startups

Osivax develops vaccines targeting conserved internal viral structures to provide broader and longer-lasting protection against influenza, leveraging its proprietary oligoDOM technology platform. The company originated from research co-developed with the University of Oxford and is supported by public health foundations and pharmaceutical partners.

1 investor

Osmol Therapeutics is a preclinical-stage biotech developing OSM-0205, an intravenous drug intended to prevent chemotherapy-induced peripheral neuropathy (CIPN) and chemotherapy-induced cognitive impairment (CICI) in cancer patients receiving taxane-based therapy. The drug targets the interaction that triggers a calcium surge leading to neuronal damage, aiming to allow optimal chemotherapy dosing.

1 investor

A medical device CRO (Contract Research Organization) and innovation platform that provides incubation, development, and commercialization services for medical devices and healthcare technologies in China and internationally.

1 investor

Ossianix develops TXP1, a brain-selective shuttle based on a deimmunised VNAR antibody scaffold that targets TfR1 to carry therapeutic payloads across the blood-brain barrier. The company focuses on improving delivery of central nervous system therapeutics to the brain.

1 investor

Domestic provider of speech and language therapy services for children with developmental and learning disorders, offering assessment, intervention, and early screening through a combination of localized international methodologies and expert supervision.

1 investor

Osteal Therapeutics is a clinical-stage pharmaceutical company developing novel treatments for orthopedic infections, particularly periprosthetic joint infections. Its lead product, NEXCHANGE KIT, is a drug-device combination designed for localized antibiotic delivery to infected joint prostheses.

1 investor

Osteocentric develops orthopedic implant systems for bone fixation, including fasteners, plates, and surgical instruments that use UnifiMI mechanical integration technology. The company serves orthopedic surgeons and hospitals treating fractures and skeletal injuries.

1 investor

Osteon Medical designs and manufactures titanium dental implant hardware, including single, bridge, and full-arch implant componentry, for dental labs and clinicians. The company operates milling and production facilities and develops digital implant solutions such as its Nexus system and intraoral scanning technology.

1 investor

Osteonic manufactures bone and reconstructive implants using metal and biodegradable composite materials, with product lines spanning craniomaxillofacial (CMF), trauma, sports medicine, spine, and dental osteosynthesis. Based in Seoul, South Korea, it supplies orthopedic surgeons and medical distributors across a global network of partners.

1 investor

Ostiio develops a fully implantable, automated distraction osteogenesis system for treating pediatric conditions such as craniosynostosis and micrognathia that restrict skull or jaw growth. Its device lets caregivers perform daily bone-lengthening distractions with a button press while giving surgeons real-time remote monitoring and control of treatment progress.

1 investor

Ostoform develops ostomy care products built around its patented FLOWASSIST technology, a non-absorbent seal with a directional spout that channels stoma output into the pouch to reduce leakage and protect peristomal skin. Its products serve ostomates and are used by healthcare professionals such as wound-care nurses in the medical device space.

1 investor

OTOFARMA is an Italian manufacturer of custom hearing aids with ISO certification, sold exclusively through partnered pharmacies. The company also offers telemedicine audiology services, positioning itself as Italy's only certified hearing aid constructor with integrated remote consultations available in over 3,000 affiliated pharmacies.

1 investor

OtoImmune is developing precision immunology products under its mOI and mOI Health brands. The page provides no further detail about the specific products, technology, or target customers.

1 investor

Otolift manufactures and sells stairlifts for residential use, offering customizable solutions for straight and curved staircases.

1 investor

Otolith Labs develops a non-invasive, headworn wearable using patented Vestibular Resonance Therapy (nVRT) to treat vestibular conditions such as vestibular migraine and chronic vertigo. The device is a non-pharmacological medical product tested in clinical studies for patients suffering from balance and vertigo disorders.

1 investor

Otologic Pharmaceutics (OPI) is a pharmaceutical company developing treatments for acute and chronic hearing loss to reduce permanent hearing disorders. Its pipeline includes an oral drug for noise-induced hearing loss and a therapy aimed at regenerating sensory hair cells.

1 investor

OtoSim develops otoscopy and ophthalmoscopy simulation tools for medical education, including desktop and smartphone-based trainers used to teach ear and eye diagnostic skills. Its products are used by medical institutions and students to improve diagnostic accuracy.

1 investor

OTS Medical develops an FDA-cleared anchoring system for arthroscopic soft-tissue-to-bone reattachment in orthopaedic surgery, including the RAPHAEL 25 anchor that can be used with or without bone marrow. Its technology targets minimally invasive soft tissue repair for orthopaedic surgeons and patients in the United States and Europe.

1 investor

ounda GmbH is a Germany-wide group that brings together independent traditional opticians and hearing-aid acousticians under one umbrella, uniting over 100 independently branded specialist stores while preserving their local identities. Founded in 2019, it positions itself as a network (not a chain) for eyewear and hearing-care retailers across Germany.

1 investor

LifeLoop provides software for senior living communities that integrates with electronic health records to reduce administrative work and keep resident data consistent across platforms. Its tools support resident engagement and experiences while aiming to improve operational efficiency and staff satisfaction.

1 investor

OurMind builds an AI platform for care professionals that takes routine clinical work such as documentation, intakes, referrals, scheduling, and follow-ups off care teams, letting clinicians create and train AI assistants across a hospital. It focuses on Dutch healthcare and is built to standards including MDR, the AI Act, NEN 7510, and ISO 27001.</parameter> <parameter name="hq_country">NL

1 investor

Outcomes operates a pharmacy clinical care platform that connects pharmacies, payers, and pharmaceutical manufacturers to manage dispensing, medication therapy management, and patient engagement. Its software supports pharmacy workflow, clinical services, medication adherence, and patient communication across the care continuum.

1 investor

OutcomesAI combines AI voice agents with licensed nurses to deliver scalable, high-quality care across hospitals, virtual care, and specialty programs. The platform automates routine clinical tasks like triage, documentation, and scheduling while enabling nurses to focus on complex, high-value patient interactions.

1 investor

Outdefine provides a governed decisioning and execution layer for clinical trial teams, using trial-trained AI inference and workflow agents to support site feasibility ranking, study risk monitoring, and real-world evidence analysis. It sits above existing clinical systems to connect trial data, protocol rules, and outcomes for pharmaceutical and life sciences operations.

1 investor